CanSino Biologics Statistics
Total Valuation
CASBF has a market cap or net worth of 1.48 billion. The enterprise value is 1.24 billion.
| Market Cap | 1.48B |
| Enterprise Value | 1.24B |
Important Dates
The last earnings date was Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 132.67M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.38% |
| Shares Change (QoQ) | -7.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 159.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 152.27 |
| PS Ratio | 12.32 |
| PB Ratio | 2.19 |
| P/TBV Ratio | 2.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -40.73 |
| EV / Sales | 10.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -19.36 |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.65 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.89 |
| Interest Coverage | -4.88 |
Financial Efficiency
Return on equity (ROE) is -4.40% and return on invested capital (ROIC) is -2.58%.
| Return on Equity (ROE) | -4.40% |
| Return on Assets (ROA) | -2.17% |
| Return on Invested Capital (ROIC) | -2.58% |
| Return on Capital Employed (ROCE) | -4.55% |
| Revenue Per Employee | 108,402 |
| Profits Per Employee | -27,478 |
| Employee Count | 1,105 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 0.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.38% in the last 52 weeks. The beta is 1.24, so CASBF's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +52.38% |
| 50-Day Moving Average | 2.99 |
| 200-Day Moving Average | 6.55 |
| Relative Strength Index (RSI) | 46.11 |
| Average Volume (20 Days) | 4,476 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CASBF had revenue of 119.78 million and -30.36 million in losses. Loss per share was -0.12.
| Revenue | 119.78M |
| Gross Profit | 86.67M |
| Operating Income | -39.25M |
| Pretax Income | -30.72M |
| Net Income | -30.36M |
| EBITDA | -15.59M |
| EBIT | -39.25M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 425.59 million in cash and 184.62 million in debt, giving a net cash position of 240.97 million.
| Cash & Cash Equivalents | 425.59M |
| Total Debt | 184.62M |
| Net Cash | 240.97M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 675.09M |
| Book Value Per Share | 2.92 |
| Working Capital | 354.82M |
Cash Flow
In the last 12 months, operating cash flow was -10.05 million and capital expenditures -53.83 million, giving a free cash flow of -63.87 million.
| Operating Cash Flow | -10.05M |
| Capital Expenditures | -53.83M |
| Free Cash Flow | -63.87M |
| FCF Per Share | n/a |
Margins
Gross margin is 72.36%, with operating and profit margins of -32.76% and -25.35%.
| Gross Margin | 72.36% |
| Operating Margin | -32.76% |
| Pretax Margin | -25.65% |
| Profit Margin | -25.35% |
| EBITDA Margin | -13.01% |
| EBIT Margin | -32.76% |
| FCF Margin | n/a |
Dividends & Yields
CASBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.38% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.06% |
| FCF Yield | -4.33% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CASBF has an Altman Z-Score of 1.93. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.93 |
| Piotroski F-Score | n/a |